Gartisertib, CAS 1613191-99-3

Product Description: Gartisertib (VX-803) is an ATP-competitive, orally active, and selective ATR inhibitor, with a Ki of 50 of 8 nM. Antitumor activity[1][2].

Applications: Cancer-Kinase/protease

Formula: C25H29F2N9O3

References: [1]Frank T. Zenke, et al. Abstract 369: Antitumor activity of M4344, a potent and selective ATR inhibitor, in monotherapy and combination therapy. Experimental and Molecular Therapeutics./[2]Gorecki L, et al. Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy. Pharmacol Ther. 2020 Feb 26:107518.

CAS Number: 1613191-99-3

Molecular Weight: 541.55

Compound Purity: 99.76

Research Area: Cancer

Solubility: DMSO : 25 mg/mL (ultrasonic)

Target: ATM/ATR

• SKU: MEXHY-136270-10.1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-136270-10.1
• Package Unit: 10 mM/1 ml
• Quantity Unit: STK